financetom
Business
financetom
/
Business
/
Pinnacle West Capital's Q2 Earnings Drop, Operating Revenue Rises; Fiscal 2025 EPS Guidance Reiterated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pinnacle West Capital's Q2 Earnings Drop, Operating Revenue Rises; Fiscal 2025 EPS Guidance Reiterated
Aug 6, 2025 6:34 AM

08:58 AM EDT, 08/06/2025 (MT Newswires) -- Pinnacle West Capital ( PNW ) reported Q2 earnings Wednesday of $1.58 per diluted share, down from $1.76 a year earlier.

A single analysts polled by FactSet expected $1.64.

Operating revenue for the quarter ended June 30 was $1.36 billion, up from $1.31 billion a year earlier.

Two analysts surveyed by FactSet expected $1.35 billion.

The company said it reiterates its fiscal 2025 EPS guidance of $4.40 to $4.60. Analysts polled by FactSet expect $4.54.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Apr 9, 2024
08:48 AM EDT, 04/09/2024 (MT Newswires) -- Consumer stocks were edging higher premarket Tuesday, with the Consumer Staples Select Sector SPDR Fund (XLP) and Consumer Discretionary Select Sector SPDR Fund (XLY) each slightly higher recently. Norwegian Cruise Line Holdings ( NCLH ) was 0.2% higher after it disclosed a new order for eight ships to be built by Italy's Fincantieri,...
Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study
Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study
Apr 9, 2024
08:49 AM EDT, 04/09/2024 (MT Newswires) -- Alkermes ( ALKS ) said Tuesday that its phase 1b study of ALKS 2680, a once-daily potential treatment for narcolepsy, showed enhanced wakefulness in patients with narcolepsy type 2 and idiopathic hypersomnia. ALKS 2680 showed clinically meaningful and statistically significant improvements in mean sleep latency compared with placebo across all doses tested in...
Oil Prices Steady Early Tuesday as Geopolitical Concerns Ease Amid Tight Supply
Oil Prices Steady Early Tuesday as Geopolitical Concerns Ease Amid Tight Supply
Apr 9, 2024
08:45 AM EDT, 04/09/2024 (MT Newswires) -- Oil prices were mostly steady early on Tuesday following two losing sessions as supply remains tight even as Middle East tensions ease slightly. West Texas Intermediate crude for May delivery was last seen down US$0.16 to US$86.27 per barrel. while June Brent crude, the global benchmark, was up US$0.02 to US$90.40. The geopolitical...
Pfizer's RSV Vaccine Meets Primary Endpoints in Study of Participants Under 60 Years; Seeks Expanded Access
Pfizer's RSV Vaccine Meets Primary Endpoints in Study of Participants Under 60 Years; Seeks Expanded Access
Apr 9, 2024
08:49 AM EDT, 04/09/2024 (MT Newswires) -- Pfizer ( PFE ) said key data from an ongoing phase 3 clinical trial of its Abrysvo vaccine, which the pharmaceutical giant is developing for the treatment of respiratory syncytial virus, or RSV, met endpoints and it's going to seek wider access for the shot. The study evaluating a single dose of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved